Sir,
Few cases of legionella infections in association with systemic lupus erythematosus (SLE) have been reported. We report here the first case of a non-fatal atypical pneumonia due to Legionella longbeachae in a woman with SLE and severe lymphopenia.
A 34-year-old woman with severe cutaneo-articular SLE was admitted for acute fever and dry cough. Her antecedents were active smoking (25 packyears) and an undocumented pneumonia 10 years previously. She was treated with hydroxychloroquine (400 mg/day), prednisone (15 mg/day), mycophenolate mofetil for 7 months (2 g/day) and belimumab for 5 months. She had previously received azathioprine for 7 years. At the diagnosis of SLE 12 years ago, a total lymphopenia (600/ mm 3 ) was observed, which progressively worsened above 400/mm 3 for 10 months. She had never received antibioprophylaxis. On admission, laboratory studies showed a C-reactive protein level of 159 mg/L, a total lymphocyte count of 226/mm 3 with a normal IgG level and no evidence of a lupus flare. Chest radiography showed an opacity in the right superior lobe. Screening for Legionella pneumophila serogroup 1 antigen in urine was negative. An acute bacterial community acquired pneumonia was suspected and probabilistic amoxicillin was initiated (3 g/day). Blood cultures were sterile. Due to persistent sepsis, amoxicillin was switched to cefotaxime (6 g/day) plus spiramycin (4.5 MUI/ day), then to piperacilline-tazobactam (12 g/day) with spiramycin continuation. Immunophenotyping showed a severe decrease in both CD4þ, CD8þ and CD19þ subsets. The bronchoalveolar culture on specific medium was suggestive of Legionella species (Figure 1) , identified as a longbeachae species by mass spectrometry and confirmed by sequencing. Tazocilline was switched to levofloxacin, and spiramycin was continued for 21 days, with a drastic improvement. Belimumab, mycophenolate-mofetil and prednisone were continued.
Smoking was stopped. Lymphocytes remained stable, ranging from 770 to 900/mm 3 for 10 months, with no further infections.
The primary reservoir of L. longbeachae is potting compost mixes. 1 In Europe and the USA, related infections occur almost exclusively in cellular immunosuppressed or splenectomized patients. [2] [3] [4] [5] [6] In SLE, lymphopenia confers an independent risk factor for severe bacterial infections. 7 Moreover, lymphopenia <500/mm 3 is rarely explored and could represent a primary immunodeficiency leading to a specific SLE phenotype. Only two cases of L. longbeachae infections have been reported in SLE, with a fatal issue for both of them. 3, 4 The first was a subacute pneumonia complicated by septic shock. The lymphocyte count was not reported. 3 The second was a pneumonia with ankle osteomyelitis. The lymphocyte count was normal but a severe neutropenia was noted. 4 The two patients were treated by prednisone alone (10-20 mg/day). On the contrary, our patient did not present with a life-threatening pneumonia, despite a severe and chronic lymphopenia and immunosuppressive drugs. We speculate that the spiramycin allowed a partial initial bacterial clearing. No environmental exposure was found. SLE, especially with lymphopenia, may confer a risk factor for severe L. longbeachae infections. In atypical pneumoniae in such patients, Legionellaspecific culture seems warranted.
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